Vaderis Therapeutics: Funding, Investors & Team (Sep 2026)
Vaderis Therapeutics is a clinical-stage biotechnology company developing targeted therapies for rare vascular diseases.
Vaderis Therapeutics has raised $152M across 1 funding round on record, the most recent a Series B of $152M announced in Aug 2026.
That round is above the $3.8M median round size for Switzerland companies tracked on FundedIQ over the last two years.
Vaderis Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Vaderis Therapeutics Funding Rounds
Vaderis Therapeutics Investors
8 investors are recorded in total; the 5 named above are those the record identifies.
Vaderis Therapeutics Founders and Leadership Team
Contact details for the Vaderis Therapeutics team: 1 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Vaderis Therapeutics Funding in Context
Vaderis Therapeutics' latest round of $152M is above the median round in Switzerland. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vaderis Therapeutics in Biotechnology and Basel
Companies Similar to Vaderis Therapeutics
xorlab is a Swiss cybersecurity company providing specialized, machine-intelligent defense against highly…
Founded in Switzerland by Julian Liniger and Adem Bilican after they struggled to find a safe, hassle-free…
NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Gravis Robotics develops autonomous technology that retrofits construction machines for earthmoving and…
Supercharging asset managers with predictive AI
Navifare is an AI travel price optimization platform that compares flight, hotel, and car rental prices from…
Exclaim Robotics develops robots to maintain AI data centers.
At SUIND, our goal is to utilize advanced technology to enhance the productivity and ecological impact of…
Ahead Health is redefining preventive healthcare by making personalized health insights clear, actionable,…
Zuriq provides adaptable quantum computing hardware that utilizes trapped ions.
Founded in Switzerland in May 2018 out of a passion to turn insights into action in the fight against…
Vaderis Therapeutics Funding FAQs
What does Vaderis Therapeutics do?
Vaderis Therapeutics is a clinical-stage biotechnology company developing targeted therapies for rare vascular diseases.
How much funding has Vaderis Therapeutics raised?
Vaderis Therapeutics has raised $152M across 1 round on record. The most recent is a Series B of $152M announced in Aug 2026.
When did Vaderis Therapeutics last raise funding?
Vaderis Therapeutics' most recent funding round on record is a Series B of $152M, announced in Aug 2026.
Who has invested in Vaderis Therapeutics?
Investors on record for Vaderis Therapeutics include TCG Crossover, Perceptive Advisors, EQT Life Sciences, Medicxi, Omega Funds. FundedIQ records 8 investors in total.
Who is the CEO of Vaderis Therapeutics?
Azmi Nabulsi is listed as President & Chief Executive Officer at Vaderis Therapeutics.
Where is Vaderis Therapeutics headquartered?
Vaderis Therapeutics is based in Basel, Switzerland.
How many employees does Vaderis Therapeutics have?
Vaderis Therapeutics is in the 11-50 employee band.
When was Vaderis Therapeutics founded?
Vaderis Therapeutics was founded in 2019.
About FundedIQ's Vaderis Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vaderis Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.